Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Impaired Glucose Tolerance (IGT) clinical trials

1 of 1 indexed Impaired Glucose Tolerance (IGT) trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Impaired Glucose Tolerance (IGT): 1 US clinical trial tracked, 1 recruiting.

Impaired Glucose Tolerance (IGT) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is The University of Texas Health Science Center at San Antonio, running 1 of these trials.

Enrollment posture brief

Registry condition impaired-glucose-tolerance-igt

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Impaired Glucose Toleran (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Impaired Glucose Tolerance (IGT)

Impaired Glucose Tolerance (IGT) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Impaired Glucose Tolerance (IGT) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Impaired Glucose Tolerance (IGT) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Impaired Glucose Tolerance (IGT) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Saxagliptin Drug
1 trials
Dapagliflozin Drug
1 trials
Pioglitazone Drug
1 trials
Metformin Drug
1 trials

US sites by state

Facility locations filed on Impaired Glucose Tolerance (IGT) trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Impaired Glucose Tolerance (IGT) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Impaired Glucose Tolerance (IGT) condition card totals 1 registered trials; most-linked intervention Saxagliptin; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.